1.
Holst Olsen I, Langer SW, Jepsen I, Assens M, Federspiel B, Preuss Hasselby J, et al. First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience. AO [Internet]. 2012 Jan. 1 [cited 2026 May 14];51(1):97-100. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/28522